Alamar Biosciences, Inc. (ALMR)
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.
$25.14+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+14.3%
The outlook
Alamar Biosciences, Inc. currently reads as leaning bullish based on above its 50- & 200-day averages, 59% of the way from its 52-week low to high, avg target +26% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range59% of the way from its 52-week low to high
Price targetAvg target +26% vs current price
Analyst price target
~12-month · 5 analysts$31.80average target+26.5% vs now
Now $25.14
Low $28.00High $35.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.74B
52-wk high
$29.43
52-wk low
$18.85
50-day avg
$23.41
200-day avg
$23.52
Trailing P/E
—